Corsano Health logo
Contact Us
B2B Procurement & Technical Integration Guide

Medical-Grade PPG ECG Multi-Sensor Device Architecture for Continuous Clinical Monitoring

Evaluating certified wrist-worn photoplethysmography (PPG) and electrocardiogram (ECG) sensor technology for hospital general wards, decentralized clinical trials, and predictive early warning algorithms.

CE-MDR Certified Class IIa FDA 510(k) Cleared ISO 13485 Manufacturing Raw PPG/ECG Data up to 128 Hz
Contact Us
  • Founded 2019 · Netherlands & Switzerland
  • 10,000+ medical devices produced
  • 35+ hospitals in clinical deployment
  • 200+ clinical research studies supported
  • 400B+ physiological data points processed
Enterprise Product Spotlight

The Corsano CardioWatch 287-2B: Next-Gen Medical-Grade PPG ECG Multi-Sensor Device

Designed specifically to bridge the clinical gap between episodic spot-check monitoring and expensive ICU telemetry systems. Corsano CardioWatch 287-2B combines multi-wavelength PPG optics, continuous single-lead ECG, and multi-modal sensing in a single Ergonomic Wristband.

Corsano Medical-Grade PPG ECG Multi-Sensor Device Ecosystem showing CardioWatch 287 bracelet, gateway application, and cloud clinician dashboard
Complete Corsano Medical-Grade PPG ECG Ecosystem: Wrist-worn multi-sensor, mobile gateway app, and cloud analytics engine.
  • Multi-Spectral Optical Sensing Array (PPG) Utilizes high-precision Green, Red, and Infrared LEDs with ultra-sensitive photodiodes to capture continuous blood volume pulse, pulse wave velocity, microvascular perfusion, and blood oxygenation (SpO2) even under motion artifacts.
  • Integrated Single-Lead ECG & Galvanic Skin Response (GSR) Embedded dry electrodes capture continuous electrical cardiac signals for arrhythmia detection, QTc interval analysis, and heart rate variability (HRV), complemented by skin conductance sensing for autonomic stress tracking.
  • Medical-Grade Surface Temperature & 3D Motion Vectoring Core temperature surrogate measurement using heat-flux compensation sensors, combined with a 3-axis accelerometer for posture tracking, continuous fall detection, and actigraphy classification.
  • Zero-Friction Clinical Workflow & High Compliance Ergonomically engineered for extended 24/7 wear across senior, pediatric, and acute care cohorts. Ultra-low power consumption delivers multi-day operation without mid-study battery recharging disruption.

Technical & Sensor Architecture Specifications

Global procurement teams in hospital IT and pharmaceutical clinical operations require transparent technical parameters. Below is the detailed breakdown of the Corsano CardioWatch 287-2B hardware and software architecture:

Parameter / Dimension CardioWatch 287-2B Specification Clinical & Operational Relevance
Primary Optical Sensor (PPG) Multi-wavelength (Green 525nm, Red 660nm, IR 940nm) Enables continuous SpO2, pulse wave morphology, and respiratory rate estimation via PPG envelope modulation.
Electrical Sensor (ECG) Single-lead dry electrode, sampling up to 128 Hz Captures high-fidelity P-QRS-T waveforms for arrhythmia screening (AFib, PVCs) and HRV spectral metrics.
Motion & Posture Sensor Low-power 3-axis accelerometer (±2g / ±4g / ±8g) Classifies physical activity, posture changes, body orientation, and artifact suppression algorithms.
Thermal & Skin Sensor Medical skin temperature (±0.1°C resolution) + GSR Monitors continuous thermoregulation changes, early fever detection, and sympathetic nervous system activation.
Regulatory Certifications EU CE-MDR (Class IIa medical device), FDA 510(k) Cleared Legally compliant for diagnostic, clinical monitoring, and regulatory trial endpoints in EU and US jurisdictions.
Data Transmission Protocols Bluetooth Low Energy 5.0, Encrypted Wi-Fi / Cellular Gateway Ensures secure continuous streaming or store-and-forward telemetry without manual patient intervention.
Software Interface Restful APIs, Mobile SDKs (iOS/Android), HL7/FHIR Bridges Directly streams continuous physiological parameters and raw signals into EMRs, EHRs, or research sandboxes.
Strategic Market Insights

Global Procurement Trends for Medical-Grade Multi-Sensor Wearables (2025–2030)

As healthcare systems migrate toward value-based care model and decentralized clinical trials (DCTs), global procurement executives face evolving technical, clinical, and regulatory evaluation criteria.

Clinician viewing continuous patient telemetry data on hospital dashboard
Trend 1: Ward-Wide Automation

Shift from Episodic Spot-Checks to Continuous Multi-Modal Telemetry

Traditional general ward care relies on manual spot-checks taken every 4 to 8 hours. Procurement data reveals a rapid industry-wide transition toward continuous multi-sensor telemetry, eliminating monitoring blind spots between nursing rounds and accelerating early intervention for patient deterioration.

  • Reduces nursing documentation time by up to 60%
  • Automates Early Warning Scores (EWS/NEWS2)
  • Prevents unexpected ICU transfers and cardiac events
Raw PPG and ECG waveform streaming illustration
Trend 2: Intellectual Property

Mandatory Access to Unprocessed Raw Optical & Electrical Signals

Enterprise buyers, biopharma sponsors, and research consortia no longer accept "black-box" proprietary algorithms. Modern tenders explicitly require full access to raw PPG (Green/Red/IR) and ECG waveforms at high sampling rates (up to 128 Hz) to train proprietary AI and ML digital biomarkers.

  • Unrestricted raw data export without vendor lock-in
  • IP-free algorithm development rights
  • Support for machine learning research pipelines
Patient monitored at home post-discharge using CardioWatch bracelet
Trend 3: Continuum of Care

Unification of Ward Monitoring and Post-Discharge Remote Patient Care

Procurement strategies are shifting away from fragmented point solutions. Health systems prioritize single-wearable platforms that transition seamlessly from acute hospital wards to post-discharge Home-at-Hospital programs using the identical device interface and patient ID.

  • Single onboarding workflow from bed to home
  • Substantially lowers hospital readmission penalties
  • Improves patient adherence with a familiar form factor
Enterprise Advantage & E-E-A-T Standard

Why Global Healthcare Organizations Partner with Corsano Health

In an industry saturated with consumer health trackers masquerading as medical tools, Corsano delivers certified clinical grade integrity backed by audited quality management systems.

  • European CE-MDR Certification (Class IIa): Full compliance with stringent EU Medical Device Regulation (MDR 2017/745), audited and verified by Notified Body Kiwa (CE 1984).
  • United States FDA 510(k) Clearance: Regulatory market clearance supporting hospital ward implementation and clinical research expansion throughout North America.
  • ISO 13485 Certified Quality Management: Stringent design, risk management, manufacturing, and post-market surveillance protocols embedded across all engineering facilities.
  • Validated Clinical Parameters: Up to 19 continuous vital sign parameters validated in clinical trials against gold-standard bedside reference monitors.
  • Robust Security & Compliance Architecture: Full data sovereignty aligned with EU GDPR and US HIPAA standards, featuring end-to-end AES-256 telemetry encryption.
Kiwa Notified Body Medical Device Certification Mark for Corsano CardioWatch
Proven Clinical Leadership

Validated by Leading Global Cardiologists & Academic Institutions

Corsano Health technology powers multi-center research, early deterioration programs, and large European innovation consortia.

I’ve tried out more wearable sensors than most people, and the CW287-2B is by far my favorite and most valuable. Congratulations to your entire team for your vision and for delivering on that. I believe your technology will have a significant impact on improving health across the globe.
Prof. Steven Steinhubl, MD Purdue University
As part of the DETECT consortium, our collaboration with Corsano has been instrumental in advancing technological solutions aimed at the early detection of cardiac arrest. This partnership is paving the way for significant breakthroughs that we believe will greatly enhance patient care and outcomes.
Prof. Niels van Royen, MD, PhD Professor of Cardiology, Head of Department, Radboud University Medical Center
CardioWatch offers automated vital signs monitoring and integrates data into health records, easing our nursing staff’s workload. Our hospital effectively addressed implementation areas like data security and legalities. We’re very pleased with our Corsano partnership.
Dr. Eelko Ronner, MD, PhD Cardiologist, Delft, Netherlands
Global Ecosystem & Commercial Alliances

Collaborating with MedTech Leaders, Global Pharma & Hospital Networks

Corsano integrates seamlessly with enterprise clinical software systems, research platforms, and global distribution logistics partners.

Netcare Hospital Network
Medtronic
Roche Diagnostics
Janssen Pharmaceuticals
Philips Health
Charité Universitätsmedizin Berlin
Radboud University Medical Center
Amsterdam UMC
Erasmus MC
Leiden University Medical Center
Buyer Knowledge Base

Global B2B Procurement FAQ: Medical-Grade PPG ECG Multi-Sensor Devices

Addressing key queries submitted by clinical evaluators, hospital procurement committees, biopharma trial directors, and software integrators.

The distinction lies in medical regulatory certification, algorithmic transparency, sensor precision, and clinical validation. Consumer smartwatches are regulated as wellness devices; their algorithms are proprietary "black boxes" designed for casual fitness, and they lack verified accuracy during motion artifacts or clinical pathology.

A true Medical-Grade PPG ECG Multi-Sensor Device, such as the Corsano CardioWatch 287-2B, is manufactured under ISO 13485 quality management, holds official CE-MDR Class IIa certification and FDA 510(k) clearance, and provides clinically validated continuous metrics. Crucially, it provides researchers and clinicians with uncompressed, IP-free raw data streams (PPG, ECG, ACC, Temp, GSR) at up to 128 Hz for legal medical decision support and digital biomarker discovery.

Corsano’s proprietary multi-sensor optical and electrical architecture combines high-frequency pulse wave signals with cardiac action potentials. Green, Red, and Infrared PPG LEDs measure peripheral blood volume changes, microvascular transit time, and continuous arterial oxygen saturation (SpO2). The integrated dry ECG electrodes capture continuous electrical cardiac depolarization waveforms.

By fusing PPG waveform envelope modulation with ECG R-R interval timing and 3D accelerometer motion vectors, the platform algorithmically derives 19 physiological metrics—including Continuous Heart Rate, Heart Rate Variability (HRV), Respiration Rate, Pulse Arrival Time (PAT), Core Body Temperature surrogate, Posture, Continuous Motion, Sleep Staging, and Early Warning Score (EWS) components.

Yes. Corsano Health provides complete, IP-free access to raw signal data streams. Through our Cloud Research Portal, RESTful APIs, and Mobile Software Development Kits (SDKs), scientific teams can export uncompressed raw 128 Hz optical PPG (Green, Red, IR), single-lead ECG waveforms, 3-axis accelerometer vectors, skin conductance (GSR), and surface temperature logs in CSV, JSON, or EDF formats.

This open architecture allows biopharmaceutical companies and AI developers to construct, test, and validate proprietary machine learning algorithms (such as automated sepsis early detection, hypertension biomarkers, or frailty scoring) without risk of vendor algorithm lock-in.

Integration is achieved through standardized medical informatics protocols. Measured vital signs and calculated Early Warning Scores (NEWS2) are formatted into HL7, FHIR, or JSON payloads. Data can be transmitted directly into leading Electronic Medical Records (EMR) solutions—including Epic, Cerner, ChipSoft HiX, and Philips CareVue—or routed to central nursing stations and custom mobile clinician applications via open REST APIs.

Corsano provides complete regulatory dossier packages for international hospital procurement tenders. This includes European CE-MDR Certificates issued by Kiwa Notified Body, FDA 510(k) clearance letters, ISO 13485 Quality Management System certificates, Clinical Evaluation Reports (CER), Declaration of Conformity (DoC), Data Protection Impact Assessment (DPIA) guidelines, and HIPAA/GDPR cybersecurity audit documentation.

The CardioWatch 287-2B is optimized for low power consumption, delivering several days of continuous multi-sensor sampling on a single wireless magnetic charge. The medical-grade enclosure is IP67 water-resistant, allowing patients to bathe without device removal. Sanitization between patient re-allocations is straightforward: the smooth, biocompatible enclosure withstands standard hospital-grade disinfectant wipes (isopropanol, quaternary ammonium compounds) in accordance with infection prevention protocols.

Accelerate Your Clinical Monitoring Strategy with Corsano Health

Request a technical consultation, evaluate pilot deployment hardware, or access our raw data developer documentation for your hospital network or research program.

Contact Us

Regulatory Notice: Feature availability, diagnostic claims, and specific sensor configurations may vary by country or geographic region based on local medical device registrations and regulatory clearances. Contact our regulatory affairs team for country-specific documentation.